Dr. Suresh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10751 Falls Road
Falls Concourse Suite 412
Lutherville, MD 21093Phone+1 410-550-5864Fax+1 410-367-2376
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2016
- Johns Hopkins UniversityChief Residency, Internal Medicine, 2012 - 2013
- Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
- University of Louisville School of MedicineClass of 2008
- University of LouisvilleBS, Mathematics , 2000 - 2004
Certifications & Licensure
- MD State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest Start of enrollment: 2020 Dec 15
Publications & Presentations
PubMed
- 17 citationsEstradiol resolves pneumonia via ERβ in regulatory T cellsYe Xiong, Qiong Zhong, Tsvi Palmer, Alison Benner, Lan Wang
JCI Insight. 2021-02-08 - 7 citationsPulmonary toxicity of immune checkpoint immunotherapy.Mohammad I Ghanbar, Karthik Suresh
The Journal of Clinical Investigation. 2024-01-16 - 229 citationsImmune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.Karthik Suresh, Jarushka Naidoo, Cheng Ting Lin, Sonye K. Danoff
Chest. 2018-12-01
Journal Articles
- Immune-Related (IR)-Pneumonitis During the COVID-19 Pandemic: Multidisciplinary Recommendations for Diagnosis and ManagementJoshua E Reuss, Karthik Suresh, David Feller-Kopman, Clare Rock, Julie R Brahmer, Journal For Immunotherapy of Cancer
- Impact of Checkpoint Inhibitor Pneumonitis on Survival in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint ImmunotherapyKarthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology
- Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk FactorsKarthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology
Press Mentions
- Researchers Characterize Lung Inflammation Associated with Some Cancer ImmnunotherapySeptember 5th, 2019
- Pharmacovigilance Needed for Immune Checkpoint Inhibitor Therapy in NSCLCAugust 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: